Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Research

Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States

Scott A. NabityComments to Author , Suzanne M. Marks, Neela D. Goswami, Shona R. Smith, Evan Timme, Sandy F. Price, Lon Gross, Julie L. Self, Katelynne Gardner Toren, Masahiro Narita, Donna H. Wegener, Shu-Hua Wang, and for the National Tuberculosis Controllers Association/CDC TB-COVID-19 Collaboration1
Author affiliations: California Department of Public Health, Richmond, California, USA (S.A. Nabity); Centers for Disease Control and Prevention, Atlanta, USA (S.A. Nabity, S.M. Marks, N.D. Goswami, S.F. Price, L. Gross, J.L. Self); Michigan Department of Health and Human Services, Lansing, Michigan, USA (S.R. Smith); Arizona Department of Health Services, Phoenix, Arizona, USA (E. Timme); Public Health–Seattle & King County, Seattle, Washington, USA (K. Gardner Toren, M. Narita); University of Washington, Seattle (M. Narita); National Tuberculosis Controllers Association, Atlanta (D.H. Wegener); The Ohio State University College of Medicine, Columbus, Ohio, USA (S.-H. Wang)

Main Article

Table 2

Multivariable log-binomial regression of characteristics for 333 persons from 25 US jurisdictions who were diagnosed with TB–COVID-19 in 2020 and persons with TB only diagnosed in 2017‒2019 or in 2020*

Characteristic 2020 TB only
 2017‒2019 TB only
uPR (95% CI) aPR (95% CI) uPR (95% CI) aPR (95% CI)
Race/ethnicity†
White Referent Referent Referent Referent
Black 0.8 (0.6‒1.1) 1.1 (0.7‒1.7) 0.9 (0.6‒1.1) 1.2 (0.7‒1.9)
Asian 0.7 (0.6‒0.9) 0.8 (0.5‒1.2) 0.7 (0.6‒0.9) 0.8 (0.5‒1.3)
Hispanic 1.6 (1.3‒2.0) 1.4 (0.9‒2.2) 1.6 (1.3‒1.9) 1.4 (0.9‒2.2)
NHOPI 2.4 (1.1‒5.4) 2.3 (1.0‒5.3) 2.2 (0.9‒5.2) 2.9 (1.1‒7.4)
American Indian/Alaska Native
 3.4 (1.4‒8.1)
 5.3 (2.1‒13.4)
2.3 (0.9‒6.0)
 3.4 (1.2‒9.6)
Origin of birth
US-born Referent Referent Referent Referent
Non–US-born
 1.4 (1.1‒1.8)
 1.5 (1.1‒2.1)
1.5 (1.1‒1.9)
 1.6 (1.1‒2.2)
AFB sputum smear result
Negative Referent NI Referent Referent
Positive 1.3 (1.0‒1.5) 1.4 (1.1‒1.7) 1.3 (1.0‒1.6)
Missing/Unknown
 0.9 (0.7‒1.2)
0.9 (0.7‒1.2)
 1.0 (0.7‒1.5)
Long-term care resident at TB diagnosis‡
No Referent Referent Referent Referent
Yes
 2.6 (1.6‒4.2)
 2.5 (1.6‒4.0)
2.5 (1.5‒4.1)
 2.4 (1.4‒4.0)
Diabetes
No Referent Referent Referent Referent
Yes
 1.8 (1.4‒2.2)
 1.6 (1.3‒2.0)
2.0 (1.6‒2.5)
 1.8 (1.4‒2.2)
End-stage renal disease
No Referent NI Referent Referent
Yes 1.8 (1.2‒2.7) 2.2 (1.4‒3.4) 1.7 (1.1‒2.7)

*Model adjusted for other variables in the table. aPR, adjusted prevalence ratio; AFB, acid-fast bacilli; NHOPI, Native Hawaiian and Other Pacific Islander; NI, not included in adjusted regression model because not statistically significant at 95% confidence level; TB, tuberculosis; TB–COVID-19, diagnosed with both TB and COVID-19 within 180 days; uPR, unadjusted prevalence ratio. †Multiple race category not included because no persons with TB–COVID-19 reported multiple races. ‡Among persons >15 years of age.

Main Article

1Group members are listed at the end of this article.

Page created: August 08, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external